S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.01 (+0.92%)
AAPL   116.59 (+0.48%)
MSFT   215.23 (+0.64%)
FB   277.81 (+0.81%)
GOOGL   1,787.02 (+1.30%)
AMZN   3,195.34 (+0.32%)
TSLA   585.76 (+2.05%)
NVDA   530.45 (+0.20%)
BABA   276.48 (-0.45%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.19 (+0.55%)
T   29.03 (+0.14%)
NIO   54.00 (+0.58%)
F   9.09 (+0.11%)
ACB   10.47 (+20.21%)
NFLX   491.36 (+1.31%)
GILD   60.03 (+0.89%)
BA   216.50 (-0.51%)
DIS   147.13 (-1.31%)
S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.01 (+0.92%)
AAPL   116.59 (+0.48%)
MSFT   215.23 (+0.64%)
FB   277.81 (+0.81%)
GOOGL   1,787.02 (+1.30%)
AMZN   3,195.34 (+0.32%)
TSLA   585.76 (+2.05%)
NVDA   530.45 (+0.20%)
BABA   276.48 (-0.45%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.19 (+0.55%)
T   29.03 (+0.14%)
NIO   54.00 (+0.58%)
F   9.09 (+0.11%)
ACB   10.47 (+20.21%)
NFLX   491.36 (+1.31%)
GILD   60.03 (+0.89%)
BA   216.50 (-0.51%)
DIS   147.13 (-1.31%)
S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.01 (+0.92%)
AAPL   116.59 (+0.48%)
MSFT   215.23 (+0.64%)
FB   277.81 (+0.81%)
GOOGL   1,787.02 (+1.30%)
AMZN   3,195.34 (+0.32%)
TSLA   585.76 (+2.05%)
NVDA   530.45 (+0.20%)
BABA   276.48 (-0.45%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.19 (+0.55%)
T   29.03 (+0.14%)
NIO   54.00 (+0.58%)
F   9.09 (+0.11%)
ACB   10.47 (+20.21%)
NFLX   491.36 (+1.31%)
GILD   60.03 (+0.89%)
BA   216.50 (-0.51%)
DIS   147.13 (-1.31%)
S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.01 (+0.92%)
AAPL   116.59 (+0.48%)
MSFT   215.23 (+0.64%)
FB   277.81 (+0.81%)
GOOGL   1,787.02 (+1.30%)
AMZN   3,195.34 (+0.32%)
TSLA   585.76 (+2.05%)
NVDA   530.45 (+0.20%)
BABA   276.48 (-0.45%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.19 (+0.55%)
T   29.03 (+0.14%)
NIO   54.00 (+0.58%)
F   9.09 (+0.11%)
ACB   10.47 (+20.21%)
NFLX   491.36 (+1.31%)
GILD   60.03 (+0.89%)
BA   216.50 (-0.51%)
DIS   147.13 (-1.31%)
Log in
ASX:CTE

Cryosite Limited (CTE.AX) Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume418 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Cryosite Limited engages in the supply chain logistics and management of pharmaceutical products used in clinical trials, and biological materials in Australia. It operates in two segments, Clinical Trials & Biological Services Logistics, and Cord Blood and Tissues Storage. The Clinical Trials & Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns, and biological storage services to the clinical trial and research industry. The Cord Blood and Tissues Storage segment offers long term storage for cord blood and tissue samples. It serves research, medical, pharmaceutical, veterinary, and biotechnology industries. Cryosite Limited was founded in 1999 and is based in South Granville, Australia.
Read More

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.58 out of 5 stars


Industry, Sector and Symbol

Stock Exchange ASX
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
Current SymbolASX:CTE
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.cryosite.com
Phone61 2 8865 2000
EmployeesN/A

Debt

Debt-to-Equity RatioN/A
Current Ratio2.06
Quick Ratio1.49

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$8.97 million
Price / Sales0.00
Cash FlowN/A
Price / Cash Flow0.55
Book ValueA($0.01) per share
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive CTE News and Ratings via Email

Sign-up to receive the latest news and ratings for CTE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Cryosite Limited (CTE.AX) (ASX:CTE) Frequently Asked Questions

What stocks does MarketBeat like better than Cryosite Limited (CTE.AX)?

Wall Street analysts have given Cryosite Limited (CTE.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cryosite Limited (CTE.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Cryosite Limited (CTE.AX)'s key competitors?

Some companies that are related to Cryosite Limited (CTE.AX) include (BUX) (BUX), 12144 (IME), BARD1 Life Sciences Limited (BD1.AX) (BD1), Charles River Laboratories International (CRL), dorsaVi Ltd (DVL.AX) (DVL), Epigenomics (EPGNY), Eternity Healthcare (ETAH), Genetic Signatures Limited (GSS.AX) (GSS), Genetic Technologies Limited (GTG.AX) (GTG), Imagion Biosystems Limited (IBX.AX) (IBX), Integral Diagnostics Limited (IDX.AX) (IDX), Lifespot Health Ltd (LSH.AX) (LSH), Medical Imaging (MEDD), OncoSil Medical Limited (OSL.AX) (OSL) and Parallax Health Sciences (PRLX).
View all competitors.

Who are Cryosite Limited (CTE.AX)'s key executives?

Cryosite Limited (CTE.AX)'s management team includes the following people:
  • Mr. Bryan Dulhunty C.A., BEc, ACA, Non-Exec. Chairman & Company Sec.
  • Mr. Mark Edmund Payton Byrne, Chief Operating Officer of Fin. & Admin.
  • Mr. John Hogg, Chief Exec. Officer

What is Cryosite Limited (CTE.AX)'s stock symbol?

Cryosite Limited (CTE.AX) trades on the ASX under the ticker symbol "CTE."

How big of a company is Cryosite Limited (CTE.AX)?

Cryosite Limited (CTE.AX) has a market capitalization of $0.00 and generates $8.97 million in revenue each year. Cryosite Limited (CTE.AX) employs 18 workers across the globe.

What is Cryosite Limited (CTE.AX)'s official website?

The official website for Cryosite Limited (CTE.AX) is www.cryosite.com.

How can I contact Cryosite Limited (CTE.AX)?

The company can be reached via phone at 61 2 8865 2000.

This page was last updated on 11/27/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.